[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $gmab $GMAB shares are up after positive news from partner $JNJ on Darzalex sales. Investors should keep an eye on $JNJ's Q2 earnings report for updated sales figures. ### About $gmab Genmab (GMAB) is a biotechnology company specializing in antibody therapeutics. ### Engagements: XXXXX [#](/topic/$gmab/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$gmab/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Month**: XXXXXXX -XX% **1-Year High**: XXXXXX on 2025-06-05 **1-Year Low**: XXX on 2025-05-04 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XXX [#](/topic/$gmab/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$gmab/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XX **1 Week**: XXX -XX% **1 Month**: XXX +335% **1-Year High**: XXX on 2025-06-27 **1-Year Low**: XX on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | XXX | ### Creators: XX [#](/topic/$gmab/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$gmab/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $gmab in the last XX hours which is up XX% from XX in the previous XX hours **Daily Average**: XX **1 Week**: XX -XX% **1 Month**: XXX +685% **1-Year High**: XXX on 2025-06-27 **1-Year Low**: XX on 2025-04-27 The most influential creators that mention $gmab in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@investseekers](/creator/twitter/investseekers) | X | XXXXX | X | XXXXX | | [@taobanker](/creator/twitter/taobanker) | X | XXXXX | X | XXX | [View More](/list/creators/$gmab/100) ### Sentiment: XX% [#](/topic/$gmab/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$gmab/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Month**: XX% -XX% **1-Year High**: XXX% on 2025-05-10 **1-Year Low**: XX% on 2025-04-28 **Most Supportive Themes** - **Strong Sales and Growth Potential:** (60%) Positive sentiment around $GMAB due to strong Darzalex sales from partner $JNJ and potential for growth. - **Investment Recommendations:** (20%) Mentions of $GMAB in the context of investment strategies and positive returns. - **Capital Allocation and Growth:** (10%) Discussions about $GMAB's capital allocation and growth prospects. **Most Critical Themes** - **Muted Reaction to Positive News:** (10%) Concerns about the muted reaction to good $JNJ numbers and the potential for a price correction. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XXX | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XXX | X% | **Top assets mentioned** In the posts about $gmab in the last XX hours [SPX6900 (SPX)](/topic/$spx) [Johnson & Johnson (JNJ)](/topic/$jnj) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Novo-Nordisk (NVO)](/topic/$nvo) [Viatris Inc (VTRS)](/topic/$vtrs) [Illumina, Inc. (ILMN)](/topic/$ilmn) [Illumina, Inc. (ILMN)](/topic/illumina-inc) [Viatris Inc (VTRS)](/topic/viatris-inc) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) **Top topics mentioned** In the posts about $gmab in the last XX hours [$gmabco](/topic/$gmabco), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [stocks technology](/topic/stocks-technology), [coins defi](/topic/coins-defi), [stocks financial services](/topic/stocks-financial-services), [stocks industrials](/topic/stocks-industrials), [investment](/topic/investment), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins base ecosystem](/topic/coins-base-ecosystem), [stocks consumer defensive](/topic/stocks-consumer-defensive), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$bntx](/topic/$bntx), [$crmd](/topic/$crmd), [stocks communication services](/topic/stocks-communication-services), [coins](/topic/coins), [$bgne](/topic/$bgne), [spx](/topic/spx), [$qqq](/topic/$qqq), [$spx](/topic/$spx), [coins exchange tokens](/topic/coins-exchange-tokens), [coins arbitrum](/topic/coins-arbitrum), [$jnj](/topic/$jnj), [johnson johnson](/topic/johnson-johnson), [$nvo](/topic/$nvo), [$vtrs](/topic/$vtrs), [$ilmn](/topic/$ilmn), [illumina inc](/topic/illumina-inc), [viatris inc](/topic/viatris-inc), [coins layer 1](/topic/coins-layer-1), [$legn](/topic/$legn), [$uthr](/topic/$uthr), [$rprx](/topic/$rprx), [$incy](/topic/$incy), [united therapeutics corp](/topic/united-therapeutics-corp), [$bmrn](/topic/$bmrn), [coins meme](/topic/coins-meme), [stocks energy](/topic/stocks-energy), [coins nft](/topic/coins-nft), [coins ai](/topic/coins-ai), [$csl](/topic/$csl), [stocks banks](/topic/stocks-banks), [$nbix](/topic/$nbix), [$insm](/topic/$insm), [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc), [coins real world assets](/topic/coins-real-world-assets), [novo](/topic/novo), [$ter](/topic/$ter), [$lian](/topic/$lian), [teradyne inc](/topic/teradyne-inc), [$exas](/topic/$exas), [$argx](/topic/$argx), [$halo](/topic/$halo), [googl](/topic/googl), [coins made in usa](/topic/coins-made-in-usa), [$googl](/topic/$googl), [$ctlt](/topic/$ctlt), [$srpt](/topic/$srpt), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [catalent inc](/topic/catalent-inc), [$itci](/topic/$itci), [$gentol](/topic/$gentol), [$rms](/topic/$rms), [$zeal](/topic/$zeal), [$bonex](/topic/$bonex), [$ipsey](/topic/$ipsey), [$labb](/topic/$labb), [$hypmy](/topic/$hypmy), [$bax](/topic/$bax), [$moh](/topic/$moh), [$xly](/topic/$xly), [$zbh](/topic/$zbh), [zimmer biomet holdings inc](/topic/zimmer-biomet-holdings-inc), [molina healthcare inc](/topic/molina-healthcare-inc), [bax baxter international inc](/topic/bax-baxter-international-inc), [$vrtx](/topic/$vrtx), [vertex protocol](/topic/vertex-protocol), [vertex pharma](/topic/vertex-pharma), [$regn](/topic/$regn), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$exel](/topic/$exel), [coins layer 2](/topic/coins-layer-2), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$abbv](/topic/$abbv), [coins pow](/topic/coins-pow), [stocks real estate](/topic/stocks-real-estate), [stocks defense](/topic/stocks-defense), [coins dao](/topic/coins-dao), [stocks basic materials](/topic/stocks-basic-materials), [$san](/topic/$san), [san san chan](/topic/san-san-chan), [banco santander](/topic/banco-santander), [coins oracle](/topic/coins-oracle), [$novcde](/topic/$novcde), [lun](/topic/lun), [teva](/topic/teva), [$lun](/topic/$lun), [$arx](/topic/$arx), [$teva](/topic/$teva) ### Top Social Posts [#](/topic/$gmab/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$GMAB shares rose XXX% yesterday after positive news from partner $JNJ on Darzalex sales. And today $NVS reported stronger-than-expected Q2 sales of Kesimpta at $1.08B vs. $1.06B expected. Genmab receives XX% royalties on Kesimpta. #stocks #investingtips" [@investseekers](/creator/x/investseekers) on [X](/post/tweet/1945742082158543322) 2025-07-17 07:07:17 UTC 2630 followers, XXX engagements "Holy moly. Darzalex sales accelerate to +23% y/y. $JNJ boosts guidance. Genmab the Giant Slayer continues to print inordinate amounts of money. $GMAB" [@taobanker](/creator/x/taobanker) on [X](/post/tweet/1945633380600611000) 2025-07-16 23:55:20 UTC 6864 followers, XXX engagements "@hiteshkar - $CRMD: it's a no-brainer you already now I guess - $GMAB: high ROCE ROE low PER (around 11) with an expected growth of 10-15%/y until 2030. Very good capital allocation - $GENT.OL: not so cheap but they will launch a new best in class diagnostic test next year" [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1945570593220297119) 2025-07-16 19:45:51 UTC XXX followers, XXX engagements "$AZN $AMGN $GILD $SNY $VRTX $REGN $ALNY $ARGX $ONC $BNTX $RPRX $INSM $BIIB $SMMT $ILMN $GMAB $INCY $UTHR $NBIX $TEM $EXEL $BMRN $ASND $VTRS $MRNA $MEDP $BPMC $VRNA $BBIO $ROIV $GRFS $RVMD $HALO $JAZZ $LEGN $MDGL $GH $IONS $NUVL $AXSM $ALKS $ADMA" [@linhnguyen64143](/creator/x/linhnguyen64143) on [X](/post/tweet/1945568276764881106) 2025-07-16 19:36:38 UTC XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$GMAB shares are up after positive news from partner $JNJ on Darzalex sales. Investors should keep an eye on $JNJ's Q2 earnings report for updated sales figures.
Genmab (GMAB) is a biotechnology company specializing in antibody therapeutics.
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-05
1-Year Low: XXX on 2025-05-04
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +335%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-04-27
Social Network | X |
---|---|
Mentions | XXX |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $gmab in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +685%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-04-27
The most influential creators that mention $gmab in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@investseekers | X | XXXXX | X | XXXXX |
@taobanker | X | XXXXX | X | XXX |
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-05-10
1-Year Low: XX% on 2025-04-28
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Top assets mentioned In the posts about $gmab in the last XX hours
SPX6900 (SPX) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Novo-Nordisk (NVO) Viatris Inc (VTRS) Illumina, Inc. (ILMN) Illumina, Inc. (ILMN) Viatris Inc (VTRS) United Therapeutics, Corp. (UTHR) Royalty Pharma plc Class A Ordinary Shares (RPRX)
Top topics mentioned In the posts about $gmab in the last XX hours
$gmabco, stocks healthcare, stocks, stocks technology, coins defi, stocks financial services, stocks industrials, investment, stocks consumer cyclical, stocks bitcoin treasuries, coins base ecosystem, stocks consumer defensive, coins solana ecosystem, $bntx, $crmd, stocks communication services, coins, $bgne, spx, $qqq, $spx, coins exchange tokens, coins arbitrum, $jnj, johnson johnson, $nvo, $vtrs, $ilmn, illumina inc, viatris inc, coins layer 1, $legn, $uthr, $rprx, $incy, united therapeutics corp, $bmrn, coins meme, stocks energy, coins nft, coins ai, $csl, stocks banks, $nbix, $insm, neurocrine biosciences inc, coins real world assets, novo, $ter, $lian, teradyne inc, $exas, $argx, $halo, googl, coins made in usa, $googl, $ctlt, $srpt, sarepta therapeutics inc, catalent inc, $itci, $gentol, $rms, $zeal, $bonex, $ipsey, $labb, $hypmy, $bax, $moh, $xly, $zbh, zimmer biomet holdings inc, molina healthcare inc, bax baxter international inc, $vrtx, vertex protocol, vertex pharma, $regn, regeneron pharmaceuticals inc, $exel, coins layer 2, stocks crypto treasuries, $abbv, coins pow, stocks real estate, stocks defense, coins dao, stocks basic materials, $san, san san chan, banco santander, coins oracle, $novcde, lun, teva, $lun, $arx, $teva
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GMAB shares rose XXX% yesterday after positive news from partner $JNJ on Darzalex sales. And today $NVS reported stronger-than-expected Q2 sales of Kesimpta at $1.08B vs. $1.06B expected. Genmab receives XX% royalties on Kesimpta. #stocks #investingtips"
@investseekers on X 2025-07-17 07:07:17 UTC 2630 followers, XXX engagements
"Holy moly. Darzalex sales accelerate to +23% y/y. $JNJ boosts guidance. Genmab the Giant Slayer continues to print inordinate amounts of money. $GMAB"
@taobanker on X 2025-07-16 23:55:20 UTC 6864 followers, XXX engagements
"@hiteshkar - $CRMD: it's a no-brainer you already now I guess - $GMAB: high ROCE ROE low PER (around 11) with an expected growth of 10-15%/y until 2030. Very good capital allocation - $GENT.OL: not so cheap but they will launch a new best in class diagnostic test next year"
@Exclamotite69 on X 2025-07-16 19:45:51 UTC XXX followers, XXX engagements
"$AZN $AMGN $GILD $SNY $VRTX $REGN $ALNY $ARGX $ONC $BNTX $RPRX $INSM $BIIB $SMMT $ILMN $GMAB $INCY $UTHR $NBIX $TEM $EXEL $BMRN $ASND $VTRS $MRNA $MEDP $BPMC $VRNA $BBIO $ROIV $GRFS $RVMD $HALO $JAZZ $LEGN $MDGL $GH $IONS $NUVL $AXSM $ALKS $ADMA"
@linhnguyen64143 on X 2025-07-16 19:36:38 UTC XX followers, XXX engagements
/topic/$gmab